Product Description
Aceneuramic acid is an N-acetylneuraminic acid that is keto-neuraminic acid in which one of the hydrogens of the amino group is replaced by an acetyl group. It is a member of N-acetylneuraminic acids, a member of acetamides and a 2-oxo monocarboxylic acid. It derives from a keto-neuraminic acid. It is a conjugate acid of an aceneuramate.
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Saudi Arabia
Approved Indications: None
Known Adverse Events: None
Company: Ultragenyx
Company Location: NOVATO CA 94949
Company CEO: Emil D. Kakkis
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: Japan